Through targeting multiple tumor-associated antigens with an investigational multi-peptide vaccine and a multi-tumor antigen adoptive (MTAA) T cell therapy, OncoPep’s T cell focused technologies are designed to be used on their own or in combination with other immunotherapeutics.
Looking for a particular OncoPep, Inc. employee's phone or email?
The OncoPep, Inc. annual revenue was $202000 in 2026.
Sanghyuck Nam is the CFO of OncoPep, Inc..
2 people are employed at OncoPep, Inc..
OncoPep, Inc. is based in Boston, Massachusetts.
The NAICS codes for OncoPep, Inc. are [32541, 54, 541, 325414, 32, 325, 3254].
The SIC codes for OncoPep, Inc. are [28, 283, 87, 873].